Log in
Enquire now
‌

Granite Bio

Developer of novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.

OverviewStructured DataIssuesContributors

Contents

granitebio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Health technology
Health technology
Biotechnology
Biotechnology
Location
Switzerland
Switzerland
Basel
Basel
CEO
‌
Patrick Loustau
Founder
‌
Patrick Loustau
Number of Employees (Ranges)
1 – 10
Email Address
info@granitebio.com
Investors
Versant Ventures
Versant Ventures
Sanofi Ventures
Sanofi Ventures
Forbion Capital Partners
Forbion Capital Partners
Novartis Venture Fund
Novartis Venture Fund
Founded Date
2021
Total Funding Amount (USD)
100,000,000
Latest Funding Round Date
April 24, 2025
Latest Funding Type
Series B
Series B

Other attributes

Latest Funding Round Amount (USD)
30,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Granite Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.